Core Viewpoint - Kintor Pharmaceutical Co., Ltd. announced the granting of stock options and restricted share units to incentivize employees and align their interests with the company's and shareholders' best interests [1] Group 1: Stock Options - The company granted 6.7405 million stock options to 348 option grantees on September 18, 2025, pending acceptance by the grantees [1] - The purpose of granting stock options is to reward employees for their past contributions to the company's success and encourage further contributions [1] Group 2: Restricted Share Units - The company also granted 1.9115 million restricted share units to 196 grantees on September 18, 2025, which is subject to acceptance by the grantees [1] - The aim of granting restricted share units is to align the interests of eligible individuals with the group's interests, encouraging retention and contributions to long-term growth and profitability [1]
科济药业-B(02171)根据首次公开发售后购股权计划授出674.05万份购股权